Tapewire

Nasdaq · USD

JBIO

Jade Biosciences, Inc.

Export transactions ↓
Tapewire entity
4757
SEC CIK
0001798749
Parsed reports
214

Last 12 months

Inside the activity.

0 purchase rows · 0 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
October 10, 2022 Filed Oct 12, 2022 17:00 UTC
Dake Benjamin TSEE REMARKS
Exercise / conversionStock Option (Right to Buy) · Derivative 4,954 $0.00 Strike: $2.14 $0.00
Disclosure

SEC source: 0001415889-22-010479 · form4-10122022_051002.xml · derivative · entry 4

Dake Benjamin T · CIK 0001869248 · SEE REMARKS

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 309,166

Underlying: Common Stock · 4,954 shares

Expires 2031-04-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 14, 2022.

F4 · derivative.exercise_date: A total of 328,921 shares subject to an employee stock option were granted on April 2, 2021, with the first installment vested on July 4, 2021, and with shares vesting in 48 substantially equal monthly installments.

Read SEC document
October 10, 2022 Filed Oct 12, 2022 17:00 UTC
Dake Benjamin TSEE REMARKS
SaleCommon Stock 1,430 $17.27 $24,688.95
Disclosure

SEC source: 0001415889-22-010479 · form4-10122022_051002.xml · nonDerivative · entry 3

Dake Benjamin T · CIK 0001869248 · SEE REMARKS

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 14, 2022.

F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $17.01 to $17.735, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

Read SEC document
October 10, 2022 Filed Oct 12, 2022 17:00 UTC
Dake Benjamin TSEE REMARKS
SaleCommon Stock 3,524 $16.74 $58,992.11
Disclosure

SEC source: 0001415889-22-010479 · form4-10122022_051002.xml · nonDerivative · entry 2

Dake Benjamin T · CIK 0001869248 · SEE REMARKS

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,430

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 14, 2022.

F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $16.00 to $16.99, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

Read SEC document
October 10, 2022 Filed Oct 12, 2022 17:00 UTC
Dake Benjamin TSEE REMARKS
Exercise / conversionCommon Stock 4,954 $2.14 $10,601.56
Disclosure

SEC source: 0001415889-22-010479 · form4-10122022_051002.xml · nonDerivative · entry 1

Dake Benjamin T · CIK 0001869248 · SEE REMARKS

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,954

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 14, 2022.

Read SEC document
October 07, 2022 Filed Oct 11, 2022 17:00 UTC
Dake Benjamin TSEE REMARKS
Exercise / conversionStock Option (Right to Buy) · Derivative 10,520 $0.00 Strike: $2.14 $0.00
Disclosure

SEC source: 0001415889-22-010429 · form4-10112022_051001.xml · derivative · entry 13

Dake Benjamin T · CIK 0001869248 · SEE REMARKS

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 314,120

Underlying: Common Stock · 10,520 shares

Expires 2031-04-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 14, 2022.

F10 · derivative.exercise_date: A total of 328,921 shares subject to an employee stock option were granted on April 2, 2021, with the first installment vested on July 4, 2021, and with shares vesting in 48 substantially equal monthly installments.

Read SEC document
October 07, 2022 Filed Oct 11, 2022 17:00 UTC
Dake Benjamin TSEE REMARKS
SaleCommon Stock 1,757 $16.41 $28,828.15
Disclosure

SEC source: 0001415889-22-010429 · form4-10112022_051001.xml · nonDerivative · entry 8

Dake Benjamin T · CIK 0001869248 · SEE REMARKS

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 14, 2022.

F6 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $16.34 to $16.52, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

Read SEC document
October 07, 2022 Filed Oct 11, 2022 17:00 UTC
Dake Benjamin TSEE REMARKS
SaleCommon Stock 8,763 $15.93 $139,631.39
Disclosure

SEC source: 0001415889-22-010429 · form4-10112022_051001.xml · nonDerivative · entry 7

Dake Benjamin T · CIK 0001869248 · SEE REMARKS

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,757

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 14, 2022.

F5 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $15.33 to $16.33, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

Read SEC document
October 07, 2022 Filed Oct 11, 2022 17:00 UTC
Dake Benjamin TSEE REMARKS
Exercise / conversionCommon Stock 10,520 $2.14 $22,512.80
Disclosure

SEC source: 0001415889-22-010429 · form4-10112022_051001.xml · nonDerivative · entry 6

Dake Benjamin T · CIK 0001869248 · SEE REMARKS

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,520

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 14, 2022.

Read SEC document
October 06, 2022 Filed Oct 11, 2022 17:00 UTC
Dake Benjamin TSEE REMARKS
Exercise / conversionStock Option (Right to Buy) · Derivative 4,281 $0.00 Strike: $2.14 $0.00
Disclosure

SEC source: 0001415889-22-010429 · form4-10112022_051001.xml · derivative · entry 12

Dake Benjamin T · CIK 0001869248 · SEE REMARKS

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 324,640

Underlying: Common Stock · 4,281 shares

Expires 2031-04-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 14, 2022.

F10 · derivative.exercise_date: A total of 328,921 shares subject to an employee stock option were granted on April 2, 2021, with the first installment vested on July 4, 2021, and with shares vesting in 48 substantially equal monthly installments.

Read SEC document
October 06, 2022 Filed Oct 11, 2022 17:00 UTC
Dake Benjamin TSEE REMARKS
Exercise / conversionStock Option (Right to Buy) · Derivative 6,348 $0.00 Strike: $2.14 $0.00
Disclosure

SEC source: 0001415889-22-010429 · form4-10112022_051001.xml · derivative · entry 11

Dake Benjamin T · CIK 0001869248 · SEE REMARKS

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,552

Underlying: Common Stock · 6,348 shares

Expires 2031-04-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 14, 2022.

F9 · derivative.exercise_date: A total of 48,882 shares subject to an employee stock option were granted on April 2, 2021, with the first installment vested on May 2, 2021, with shares vesting in 48 substantially equal monthly installments.

Read SEC document
October 06, 2022 Filed Oct 11, 2022 17:00 UTC
Dake Benjamin TSEE REMARKS
Exercise / conversionStock Option (Right to Buy) · Derivative 1,506 $0.00 Strike: $1.74 $0.00
Disclosure

SEC source: 0001415889-22-010429 · form4-10112022_051001.xml · derivative · entry 10

Dake Benjamin T · CIK 0001869248 · SEE REMARKS

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 33,150

Underlying: Common Stock · 1,506 shares

Expires 2030-09-03

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 14, 2022.

F8 · derivative.exercise_date: A total of 72,325 shares subject to an employee stock option were granted on September 4, 2020, with 25% of the shares vested on August 1, 2021, and the remainder vesting in 36 substantially equal monthly installments thereafter.

Read SEC document
October 06, 2022 Filed Oct 11, 2022 17:00 UTC
Dake Benjamin TSEE REMARKS
Exercise / conversionStock Option (Right to Buy) · Derivative 905 $0.00 Strike: $1.74 $0.00
Disclosure

SEC source: 0001415889-22-010429 · form4-10112022_051001.xml · derivative · entry 9

Dake Benjamin T · CIK 0001869248 · SEE REMARKS

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,583

Underlying: Common Stock · 905 shares

Expires 2030-09-03

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 14, 2022.

F7 · derivative.exercise_date: A total of 48,293 shares subject to an employee stock option were granted on September 4, 2020, with 10% of the shares vested on January 1, 2020, an additional 22.5% of the shares vested on January 1, 2021, and the remainder vesting in 36 substantially equal monthly installments thereafter.

Read SEC document
October 06, 2022 Filed Oct 11, 2022 17:00 UTC
Dake Benjamin TSEE REMARKS
SaleCommon Stock 948 $17.31 $16,410.64
Disclosure

SEC source: 0001415889-22-010429 · form4-10112022_051001.xml · nonDerivative · entry 5

Dake Benjamin T · CIK 0001869248 · SEE REMARKS

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 14, 2022.

F4 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $15.095 to $16.075, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

Read SEC document
October 06, 2022 Filed Oct 11, 2022 17:00 UTC
Dake Benjamin TSEE REMARKS
SaleCommon Stock 882 $16.54 $14,588.63
Disclosure

SEC source: 0001415889-22-010429 · form4-10112022_051001.xml · nonDerivative · entry 4

Dake Benjamin T · CIK 0001869248 · SEE REMARKS

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 948

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 14, 2022.

F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $15.095 to $16.075, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

Read SEC document
October 06, 2022 Filed Oct 11, 2022 17:00 UTC
Dake Benjamin TSEE REMARKS
SaleCommon Stock 11,210 $15.64 $175,344.58
Disclosure

SEC source: 0001415889-22-010429 · form4-10112022_051001.xml · nonDerivative · entry 3

Dake Benjamin T · CIK 0001869248 · SEE REMARKS

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,830

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 14, 2022.

F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $15.095 to $16.075, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

Read SEC document
October 06, 2022 Filed Oct 11, 2022 17:00 UTC
Dake Benjamin TSEE REMARKS
Exercise / conversionCommon Stock 10,629 $2.14 $22,746.06
Disclosure

SEC source: 0001415889-22-010429 · form4-10112022_051001.xml · nonDerivative · entry 2

Dake Benjamin T · CIK 0001869248 · SEE REMARKS

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,040

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 14, 2022.

Read SEC document
October 06, 2022 Filed Oct 11, 2022 17:00 UTC
Dake Benjamin TSEE REMARKS
Exercise / conversionCommon Stock 2,411 $1.74 $4,195.14
Disclosure

SEC source: 0001415889-22-010429 · form4-10112022_051001.xml · nonDerivative · entry 1

Dake Benjamin T · CIK 0001869248 · SEE REMARKS

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,411

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 14, 2022.

Read SEC document
October 05, 2022 Filed Oct 7, 2022 17:00 UTC
NIVEN RALPHCHIEF SCIENTIFIC OFFICER
Exercise / conversionStock Option (Right to Buy) · Derivative 750 $0.00 Strike: $2.14 $0.00
Disclosure

SEC source: 0001415889-22-010412 · form4-10072022_051021.xml · derivative · entry 9

NIVEN RALPH · CIK 0001168060 · CHIEF SCIENTIFIC OFFICER

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 57,482

Underlying: Common Stock · 750 shares

Expires 2031-04-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on July 6, 2022.

F8 · derivative.exercise_date: A total of 59,732 shares subject to an employee stock option were granted on April 2, 2021, with options vesting in 48 equal monthly installments, with the first installment vested on July 4, 2021.

Read SEC document
October 05, 2022 Filed Oct 7, 2022 17:00 UTC
NIVEN RALPHCHIEF SCIENTIFIC OFFICER
Exercise / conversionStock Option (Right to Buy) · Derivative 650 $0.00 Strike: $2.14 $0.00
Disclosure

SEC source: 0001415889-22-010412 · form4-10072022_051021.xml · derivative · entry 8

NIVEN RALPH · CIK 0001168060 · CHIEF SCIENTIFIC OFFICER

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 47,958

Underlying: Common Stock · 650 shares

Expires 2031-04-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on July 6, 2022.

F7 · derivative.exercise_date: A total of 49,908 shares subject to an employee stock option were granted on April 2, 2021, with options vesting in 48 equal monthly installments, with the first installment vested on July 4, 2021.

Read SEC document
October 05, 2022 Filed Oct 7, 2022 17:00 UTC
NIVEN RALPHCHIEF SCIENTIFIC OFFICER
Exercise / conversionStock Option (Right to Buy) · Derivative 200 $0.00 Strike: $2.14 $0.00
Disclosure

SEC source: 0001415889-22-010412 · form4-10072022_051021.xml · derivative · entry 7

NIVEN RALPH · CIK 0001168060 · CHIEF SCIENTIFIC OFFICER

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,694

Underlying: Common Stock · 200 shares

Expires 2031-04-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on July 6, 2022.

F6 · derivative.exercise_date: A total of 16,294 shares subject to an employee stock option were granted on April 2, 2021, with options vesting in 48 equal monthly installments, with the first installment vested on May 2, 2021.

Read SEC document
October 05, 2022 Filed Oct 7, 2022 17:00 UTC
NIVEN RALPHCHIEF SCIENTIFIC OFFICER
Exercise / conversionStock Option (Right to Buy) · Derivative 200 $0.00 Strike: $1.74 $0.00
Disclosure

SEC source: 0001415889-22-010412 · form4-10072022_051021.xml · derivative · entry 6

NIVEN RALPH · CIK 0001168060 · CHIEF SCIENTIFIC OFFICER

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,888

Underlying: Common Stock · 200 shares

Expires 2030-09-03

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on July 6, 2022.

F5 · derivative.exercise_date: A total of 14,488 shares subject to an employee stock option were granted on September 4, 2020, with 25% of this option vested on June 1, 2021, and the remainder vesting in 36 substantially equal monthly installments thereafter.

Read SEC document
October 05, 2022 Filed Oct 7, 2022 17:00 UTC
NIVEN RALPHCHIEF SCIENTIFIC OFFICER
Exercise / conversionStock Option (Right to Buy) · Derivative 450 $0.00 Strike: $1.74 $0.00
Disclosure

SEC source: 0001415889-22-010412 · form4-10072022_051021.xml · derivative · entry 5

NIVEN RALPH · CIK 0001168060 · CHIEF SCIENTIFIC OFFICER

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,758

Underlying: Common Stock · 450 shares

Expires 2030-09-03

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on July 6, 2022.

F4 · derivative.exercise_date: A total of 24,108 shares subject to an employee stock option were granted on September 4, 2020, with 25% of this option vested on August 1, 2021, and the remainder vesting in 36 substantially equal monthly installments thereafter.

Read SEC document
October 05, 2022 Filed Oct 7, 2022 17:00 UTC
NIVEN RALPHCHIEF SCIENTIFIC OFFICER
SaleCommon Stock 191 $16.22 $3,097.64
Disclosure

SEC source: 0001415889-22-010412 · form4-10072022_051021.xml · nonDerivative · entry 4

NIVEN RALPH · CIK 0001168060 · CHIEF SCIENTIFIC OFFICER

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,609

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on July 6, 2022.

F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $16.21 to $16.41, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

Read SEC document
October 05, 2022 Filed Oct 7, 2022 17:00 UTC
NIVEN RALPHCHIEF SCIENTIFIC OFFICER
SaleCommon Stock 2,059 $15.71 $32,348.95
Disclosure

SEC source: 0001415889-22-010412 · form4-10072022_051021.xml · nonDerivative · entry 3

NIVEN RALPH · CIK 0001168060 · CHIEF SCIENTIFIC OFFICER

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,800

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on July 6, 2022.

F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $15.13 to $16.11, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

Read SEC document
October 05, 2022 Filed Oct 7, 2022 17:00 UTC
NIVEN RALPHCHIEF SCIENTIFIC OFFICER
Exercise / conversionCommon Stock 1,600 $2.14 $3,424.00
Disclosure

SEC source: 0001415889-22-010412 · form4-10072022_051021.xml · nonDerivative · entry 2

NIVEN RALPH · CIK 0001168060 · CHIEF SCIENTIFIC OFFICER

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,859

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on July 6, 2022.

Read SEC document
October 05, 2022 Filed Oct 7, 2022 17:00 UTC
NIVEN RALPHCHIEF SCIENTIFIC OFFICER
Exercise / conversionCommon Stock 650 $1.74 $1,131.00
Disclosure

SEC source: 0001415889-22-010412 · form4-10072022_051021.xml · nonDerivative · entry 1

NIVEN RALPH · CIK 0001168060 · CHIEF SCIENTIFIC OFFICER

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,259

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on July 6, 2022.

Read SEC document
September 12, 2022 Filed Sep 14, 2022 17:15 UTC
Dake Benjamin TSEE REMARKS
Exercise / conversionStock Option (Right to Buy) · Derivative 7,520 $0.00 Strike: $2.14 $0.00
Disclosure

SEC source: 0001415889-22-009612 · form4-09142022_050901.xml · derivative · entry 5

Dake Benjamin T · CIK 0001869248 · SEE REMARKS

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 36,900

Underlying: Common Stock · 7,520 shares

Expires 2031-04-02

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 14, 2022.

F5 · derivative.exercise_date: A total of 48,882 shares subject to an employee stock option were granted on April 2, 2021, with shares vesting in 48 substantially equal monthly installments.

Read SEC document
September 12, 2022 Filed Sep 14, 2022 17:15 UTC
Dake Benjamin TSEE REMARKS
SaleCommon Stock 272 $18.77 $5,104.90
Disclosure

SEC source: 0001415889-22-009612 · form4-09142022_050901.xml · nonDerivative · entry 4

Dake Benjamin T · CIK 0001869248 · SEE REMARKS

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 14, 2022.

F4 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $18.72 to $18.86, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

Read SEC document
September 12, 2022 Filed Sep 14, 2022 17:15 UTC
Dake Benjamin TSEE REMARKS
SaleCommon Stock 1,976 $18.26 $36,086.90
Disclosure

SEC source: 0001415889-22-009612 · form4-09142022_050901.xml · nonDerivative · entry 3

Dake Benjamin T · CIK 0001869248 · SEE REMARKS

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 272

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 14, 2022.

F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $17.595 to $18.54, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

Read SEC document
September 12, 2022 Filed Sep 14, 2022 17:15 UTC
Dake Benjamin TSEE REMARKS
SaleCommon Stock 5,272 $16.90 $89,114.72
Disclosure

SEC source: 0001415889-22-009612 · form4-09142022_050901.xml · nonDerivative · entry 2

Dake Benjamin T · CIK 0001869248 · SEE REMARKS

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,248

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 14, 2022.

F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $16.59 to $17.58, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

Read SEC document
September 12, 2022 Filed Sep 14, 2022 17:15 UTC
Dake Benjamin TSEE REMARKS
Exercise / conversionCommon Stock 7,520 $2.14 $16,092.80
Disclosure

SEC source: 0001415889-22-009612 · form4-09142022_050901.xml · nonDerivative · entry 1

Dake Benjamin T · CIK 0001869248 · SEE REMARKS

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,520

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 14, 2022.

Read SEC document
September 09, 2022 Filed Sep 12, 2022 17:30 UTC
Dake Benjamin TSee Remarks
Exercise / conversionStock Option (Right to Buy) · Derivative 4,462 $0.00 Strike: $2.14 $0.00
Disclosure

SEC source: 0001493152-22-025660 · ownership.xml · derivative · entry 11

Dake Benjamin T · CIK 0001869248 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 44,420

Underlying: Common Stock · 4,462 shares

Expires 2031-04-02

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 14, 2022.

F8 · derivative.exercise_date: A total of 48,882 shares subject to an employee stock option were granted on April 2, 2021, with shares vesting in 48 substantially equal monthly installments.

Read SEC document
September 09, 2022 Filed Sep 12, 2022 17:30 UTC
Dake Benjamin TSee Remarks
Exercise / conversionStock Option (Right to Buy) · Derivative 258 $0.00 Strike: $1.74 $0.00
Disclosure

SEC source: 0001493152-22-025660 · ownership.xml · derivative · entry 10

Dake Benjamin T · CIK 0001869248 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,488

Underlying: Common Stock · 258 shares

Expires 2030-09-03

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 14, 2022.

F6 · derivative.exercise_date: A total of 48,293 shares subject to an employee stock option were granted on September 4, 2020, with 10% of the shares vested on January 1, 2020, an additional 22.5% of the shares vested on January 1, 2021, and the remainder vesting in 36 substantially equal monthly installments thereafter.

Read SEC document
September 09, 2022 Filed Sep 12, 2022 17:30 UTC
Dake Benjamin TSee Remarks
SaleCommon Stock 176 $18.54 $3,262.32
Disclosure

SEC source: 0001493152-22-025660 · ownership.xml · nonDerivative · entry 7

Dake Benjamin T · CIK 0001869248 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 14, 2022.

F5 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $18.07 to $18.75, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

Read SEC document
September 09, 2022 Filed Sep 12, 2022 17:30 UTC
Dake Benjamin TSee Remarks
SaleCommon Stock 4,544 $17.50 $79,540.45
Disclosure

SEC source: 0001493152-22-025660 · ownership.xml · nonDerivative · entry 6

Dake Benjamin T · CIK 0001869248 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 176

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 14, 2022.

F4 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $17.06 to $18.06, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

Read SEC document
September 09, 2022 Filed Sep 12, 2022 17:30 UTC
Dake Benjamin TSee Remarks
Exercise / conversionCommon Stock 4,462 $2.14 $9,548.68
Disclosure

SEC source: 0001493152-22-025660 · ownership.xml · nonDerivative · entry 5

Dake Benjamin T · CIK 0001869248 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,720

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 14, 2022.

Read SEC document
September 09, 2022 Filed Sep 12, 2022 17:30 UTC
Dake Benjamin TSee Remarks
Exercise / conversionCommon Stock 258 $1.74 $448.92
Disclosure

SEC source: 0001493152-22-025660 · ownership.xml · nonDerivative · entry 4

Dake Benjamin T · CIK 0001869248 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 258

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 14, 2022.

Read SEC document
September 08, 2022 Filed Sep 12, 2022 17:30 UTC
Dake Benjamin TSee Remarks
Exercise / conversionStock Option (Right to Buy) · Derivative 2,472 $0.00 Strike: $1.74 $0.00
Disclosure

SEC source: 0001493152-22-025660 · ownership.xml · derivative · entry 9

Dake Benjamin T · CIK 0001869248 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 34,656

Underlying: Common Stock · 2,472 shares

Expires 2030-09-03

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 14, 2022.

F7 · derivative.exercise_date: A total of 72,325 shares subject to an employee stock option were granted on September 4, 2020, with 25% of the shares vested on August 1, 2021, and the remainder vesting in 36 substantially equal monthly installments thereafter.

Read SEC document
September 08, 2022 Filed Sep 12, 2022 17:30 UTC
Dake Benjamin TSee Remarks
Exercise / conversionStock Option (Right to Buy) · Derivative 648 $0.00 Strike: $1.74 $0.00
Disclosure

SEC source: 0001493152-22-025660 · ownership.xml · derivative · entry 8

Dake Benjamin T · CIK 0001869248 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,746

Underlying: Common Stock · 648 shares

Expires 2030-09-03

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 14, 2022.

F6 · derivative.exercise_date: A total of 48,293 shares subject to an employee stock option were granted on September 4, 2020, with 10% of the shares vested on January 1, 2020, an additional 22.5% of the shares vested on January 1, 2021, and the remainder vesting in 36 substantially equal monthly installments thereafter.

Read SEC document
September 08, 2022 Filed Sep 12, 2022 17:30 UTC
Dake Benjamin TSee Remarks
SaleCommon Stock 629 $18.42 $11,588.32
Disclosure

SEC source: 0001493152-22-025660 · ownership.xml · nonDerivative · entry 3

Dake Benjamin T · CIK 0001869248 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 14, 2022.

F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $18.40 to $18.505, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

Read SEC document
September 08, 2022 Filed Sep 12, 2022 17:30 UTC
Dake Benjamin TSee Remarks
SaleCommon Stock 2,491 $18.14 $45,193.22
Disclosure

SEC source: 0001493152-22-025660 · ownership.xml · nonDerivative · entry 2

Dake Benjamin T · CIK 0001869248 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 629

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 14, 2022.

F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $17.39 to $18.385, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

Read SEC document
September 08, 2022 Filed Sep 12, 2022 17:30 UTC
Dake Benjamin TSee Remarks
Exercise / conversionCommon Stock 3,120 $1.74 $5,428.80
Disclosure

SEC source: 0001493152-22-025660 · ownership.xml · nonDerivative · entry 1

Dake Benjamin T · CIK 0001869248 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,120

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 14, 2022.

Read SEC document
September 07, 2022 Filed Sep 8, 2022 17:30 UTC
Dake Benjamin TSee Remarks
Exercise / conversionStock Option (Right to Buy) · Derivative 8,220 $0.00 Strike: $1.74 $0.00
Disclosure

SEC source: 0001493152-22-025399 · ownership.xml · derivative · entry 9

Dake Benjamin T · CIK 0001869248 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 37,128

Underlying: Common Stock · 8,220 shares

Expires 2030-09-03

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 14, 2022.

F7 · derivative.exercise_date: A total of 72,325 shares subject to an employee stock option were granted on September 4, 2020, with 25% of the shares vested on August 1, 2021, and the remainder vesting in 36 substantially equal monthly installments thereafter.

Read SEC document
September 07, 2022 Filed Sep 8, 2022 17:30 UTC
Dake Benjamin TSee Remarks
SaleCommon Stock 3,658 $18.42 $67,386.21
Disclosure

SEC source: 0001493152-22-025399 · ownership.xml · nonDerivative · entry 7

Dake Benjamin T · CIK 0001869248 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 14, 2022.

F6 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $18.345 to $18.625, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

Read SEC document
September 07, 2022 Filed Sep 8, 2022 17:30 UTC
Dake Benjamin TSee Remarks
SaleCommon Stock 4.562 $18.12 $82.65
Disclosure

SEC source: 0001493152-22-025399 · ownership.xml · nonDerivative · entry 6

Dake Benjamin T · CIK 0001869248 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,658

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 14, 2022.

F5 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $17.32 to $18.32, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

Read SEC document
September 07, 2022 Filed Sep 8, 2022 17:30 UTC
Dake Benjamin TSee Remarks
Exercise / conversionCommon Stock 8,220 $1.74 $14,302.80
Disclosure

SEC source: 0001493152-22-025399 · ownership.xml · nonDerivative · entry 5

Dake Benjamin T · CIK 0001869248 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,220

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 14, 2022.

Read SEC document
September 06, 2022 Filed Sep 7, 2022 17:30 UTC
NIVEN RALPHChief Scientific Officer
Exercise / conversionStock Option (Right to Buy) · Derivative 750 $0.00 Strike: $2.14 $0.00
Disclosure

SEC source: 0001493152-22-025289 · ownership.xml · derivative · entry 8

NIVEN RALPH · CIK 0001168060 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 58,232

Underlying: Common Stock · 750 shares

Expires 2031-04-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on July 6, 2022.

F6 · derivative.exercise_date: A total of 59,732 shares subject to an employee stock option were granted on April 2, 2021, with options vesting in 48 equal monthly installments, with the first installment vested on July 4, 2021.

Read SEC document
September 06, 2022 Filed Sep 7, 2022 17:30 UTC
NIVEN RALPHChief Scientific Officer
Exercise / conversionStock Option (Right to Buy) · Derivative 650 $0.00 Strike: $2.14 $0.00
Disclosure

SEC source: 0001493152-22-025289 · ownership.xml · derivative · entry 7

NIVEN RALPH · CIK 0001168060 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 48,608

Underlying: Common Stock · 650 shares

Expires 2031-04-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on July 6, 2022.

F5 · derivative.exercise_date: A total of 49,908 shares subject to an employee stock option were granted on April 2, 2021, with options vesting in 48 equal monthly installments, with the first installment vested on July 4, 2021.

Read SEC document
September 06, 2022 Filed Sep 7, 2022 17:30 UTC
NIVEN RALPHChief Scientific Officer
Exercise / conversionStock Option (Right to Buy) · Derivative 200 $0.00 Strike: $2.14 $0.00
Disclosure

SEC source: 0001493152-22-025289 · ownership.xml · derivative · entry 6

NIVEN RALPH · CIK 0001168060 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,894

Underlying: Common Stock · 200 shares

Expires 2031-04-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on July 6, 2022.

F4 · derivative.exercise_date: A total of 16,294 shares subject to an employee stock option were granted on April 2, 2021, with options vesting in 48 equal monthly installments, with the first installment vested on May 2, 2021.

Read SEC document
September 06, 2022 Filed Sep 7, 2022 17:30 UTC
NIVEN RALPHChief Scientific Officer
Exercise / conversionStock Option (Right to Buy) · Derivative 200 $0.00 Strike: $1.74 $0.00
Disclosure

SEC source: 0001493152-22-025289 · ownership.xml · derivative · entry 5

NIVEN RALPH · CIK 0001168060 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,088

Underlying: Common Stock · 200 shares

Expires 2030-09-03

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on July 6, 2022.

F3 · derivative.exercise_date: A total of 14,488 shares subject to an employee stock option were granted on September 4, 2020, with 25% of this option vested on June 1, 2021, and the remainder vesting in 36 substantially equal monthly installments thereafter.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.